Mesenchymal stem/stromal cell therapy in atopic dermatitis and chronic urticaria: immunological and clinical viewpoints.
Stem Cell Res Ther
; 12(1): 539, 2021 10 11.
Article
in English
| MEDLINE | ID: covidwho-1854868
ABSTRACT
Allergic diseases are immune-mediated diseases. Allergies share a common immunopathogenesis, with specific differences according to the specific disease. Mesenchymal stem/stromal cells (MSCs) have been applied to people suffering from allergic and many other diseases. In this review, the immunologic roles of MSCs are systemically reviewed according to disease immunopathogenesis from a clinical viewpoint. MSCs seem to be a promising therapeutic modality not only as symptomatic treatments but also as causative and even preventive treatments for allergic diseases, including atopic dermatitis and chronic urticaria.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Dermatitis, Atopic
/
Mesenchymal Stem Cells
/
Chronic Urticaria
/
Hypersensitivity
Type of study:
Prognostic study
Limits:
Humans
Language:
English
Journal:
Stem Cell Res Ther
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS